Earnings History Data for Gracell Biotechnologies Inc. (GRCL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company. It involved in discovering and developing breakthrough cell therapies to address unmet medical needs in the treatment of cancer. Gracell Biotechnologies Inc. is based in SUZHOU, China.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-11-2023	PM		GRCL	Gracell Biotechnologies Inc.	287.72	-0.10	-0.26	-0.36	Gracell Biotechnologies Q3 GAAP EPS of -$0.51 misses by $0.38 [11/13/2023 10:50 AM]	4.60	0.20 (4.55%)	4.49	0.09 (2.05%)	1.40 - 6.99	278,810	530,000	9,024
Gracell Biotechnologies Q3 GAAP EPS of -$0.51 misses by $0.38 [11/13/2023 10:50 AM]
14-08-2023	PM		GRCL	Gracell Biotechnologies Inc.	253.87	-0.30	-0.37	-0.32	Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07 [8/14/2023 7:23 AM]	3.92	0.08 (2.08%)	0.0	0.0 (0.00%)	1.40 - 6.99	127,360	190,000	0
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07 [8/14/2023 7:23 AM]
15-05-2023	PM	7:15 AM ET (May 15)	GRCL	Gracell Biotechnologies Inc.	138.78	-0.35	-0.35	-0.37	Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.08 [5/15/2023 7:19 AM]	2.25	0.21 (10.29%)	0.0	0.0 (0.00%)	1.40 - 5.69	105,690	120,000	0
Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.08 [5/15/2023 7:19 AM]
13-03-2023	PM	7:15 AM ET (Mar 13)	GRCL	Gracell Biotechnologies Inc.	142.14	-0.30	-0.43	-0.30	Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07 [3/13/2023 7:41 AM]	1.79	-0.07 (-3.76%)	0.0	0.0 (0.00%)	1.68 - 5.69	47,479	80,000	0
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07 [3/13/2023 7:41 AM]
14-11-2022	PM	7:15 AM ET (Nov 14)	GRCL	Gracell Biotechnologies	256.00	-0.36	-0.09	0.00	Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.01 [11/14/2022 7:21 AM]	4.04	0.29 (7.73%)	0.0	0.0 (0.00%)	1.68 - 11.80	29,233	30,000	0
Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.01 [11/14/2022 7:21 AM]
15-08-2022	PM	7:30 AM ET (Aug 15)	GRCL	Gracell Biotechnologies Inc.	249.46	-0.32	-0.08	-0.22	Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.02 [8/15/2022 7:23 AM]	3.41	0.03 (0.89%)	3.38	0.0 (0.00%)	1.68 - 15.00	141,309	70,000	318
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.02 [8/15/2022 7:23 AM] Gracell Biotechnologies Reports Second Quarter 2022 Unaudited Financial Results and Provides Corporate Update [Aug-15-22 07:15AM]
16-05-2022	PM	7:30 AM ET (May 16)	GRCL	Gracell Biotechnologies Inc.	217.47	-0.37	-0.08	-0.25	Gracell Biotechnologies GAAP EPS of -$0.07 in-line [5/16/2022 7:37 AM]	3.38	0.05 (1.50%)	3.31	-0.02 (-0.60%)	1.68 - 19.74	74,253	100,000	1,395
Gracell Biotechnologies GAAP EPS of -$0.07 in-line [5/16/2022 7:37 AM] Gracell Biotechnologies Reports First Quarter 2022 Unaudited Financial Results and Provides Corporate Update [May-16-22 07:30AM]
14-03-2022	PM	7:30 AM ET (Mar 14)	GRCL	Gracell Biotechnologies Inc.	194.40	-0.30	-0.38	0.00	Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.10 [3/14/2022 7:32 AM]	1.85	-0.70 (-27.45%)	2.51	-0.04 (-1.57%)	1.68 - 24.58	222,435	256,361	1,684
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.10 [3/14/2022 7:32 AM] Gracell Biotechnologies Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results and Provides Corporate Update [Mar-14-22 07:30AM]
17-08-2021	PM	8:00 AM ET (Aug 17)	GRCL	Gracell Biotechnologies Inc.	779.00	-0.22	-0.05	0.00	Gracell Biotechnologies EPS beats by $0.08 [8/17/2021 7:07 AM]	10.65	-1.28 (-10.73%)	12.40	0.47 (3.94%)	9.75 - 33.70	75,511	70,000	2,895
Gracell inks exclusive license agreement with FutureGen Biopharm [8/16/2021 8:30 AM] Gracell Biotechnologies EPS beats by $0.08 [8/17/2021 7:07 AM] Gracell Biotechnologies shares fall after wider Q2 net loss, cash position update [8/17/2021 10:38 AM] Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors [Aug-16-21 08:00AM] Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corporate Update [Aug-17-21 07:00AM]
09-03-2021	AH	After the close (Mar 9)	GRCL	Gracell Biotechnologies Inc.	1,380	N/A	-0.27	0.00	Gracell Biotechnologies EPS misses by $0.32 [3/9/2021 4:07 PM]	22.48	0.31 (1.40%)	0.0	0.0 (0.00%)	20.12 - 33.70	33,442	73,490	0
Gracell Biotechnologies EPS misses by $0.32 [3/9/2021 4:07 PM] Gracell Biotechnologies Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results and Provides Corporate Update [Mar-09-21 04:01PM] Gracell Biotechnologies Inc - ADR to Host Earnings Call [Mar-10-21 05:15AM]